Results for nexmed. Search took 0.07 seconds.
NexMed Licenses Nail Fungus Drug to Novartis
in The Biotech Weblog, on September 16, 2005
...
Novartis AG gets exclusive worldwide rights to NexMed 's proprietary NM100060 nail lacquer treatment for onychomycosis , commonly known as nail fungus. NM100060 is currently in Phase 1...



